Updated Jul 16, 2026 · Last SEC filing 2026-07-09
ABEONA THERAPEUTICS INC. (ABEO) has filed 15 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-09. 5 Form 8-K material event filings were reported by ABEO in the last 90 days. 14 Form 144 notices of proposed sale were filed for ABEO stock. InsiderAlpha tracks every ABEO SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0000318306 |
| Form 4 filings (90d) | 15 |
|---|---|
| Form 8-K filings (90d) | 5 |
| Form 144 notices (90d) | 14 |
| Latest Form 4 filing | 2026-07-09 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Seshadri Vishwas | Chief Executive Officer | S — Open-market sale | 68.0K | $6.96 | $473K | SEC | |
| Vazzano Joseph Walter | Chief Financial Officer | S — Open-market sale | 24.9K | $6.96 | $173K | SEC | |
| Vasanthavada Madhav | Chief Commercial Officer | S — Open-market sale | 12.6K | $6.96 | $88K | SEC | |
| O'Malley Brendan M. | SVP, Chief Legal Officer | S — Open-market sale | 12.1K | $6.96 | $84K | SEC | |
| Alland Leila | Director | S — Open-market sale | 11.0K | $5.92 | $65K | SEC | |
| Vasanthavada Madhav | Chief Commercial Officer | J — Other acquisition / disposition | 222 | $5.67 | $1K | SEC | |
| Silverstein Christine Berni | Director | S — Open-market sale | 18.2K | $5.71 | $104K | SEC | |
| Vazzano Joseph Walter | Chief Financial Officer | S — Open-market sale | 25.6K | $5.39 | $138K | SEC | |
| O'Malley Brendan M. | SVP, Chief Legal Officer | S — Open-market sale | 6.3K | $5.30 | $33K | SEC | |
| Vasanthavada Madhav | Chief Commercial Officer | S — Open-market sale | 5.5K | $5.30 | $29K | SEC | |
| Seshadri Vishwas | Chief Executive Officer | S — Open-market sale | 31.9K | $5.30 | $169K | SEC | |
| Vazzano Joseph Walter | Chief Financial Officer | S — Open-market sale | 13.4K | $5.30 | $71K | SEC | |
| O'Malley Brendan M. | SVP, Chief Legal Officer | S — Open-market sale | 4.8K | $5.43 | $26K | SEC | |
| Vasanthavada Madhav | Chief Commercial Officer | S — Open-market sale | 4.2K | $5.43 | $23K | SEC | |
| Seshadri Vishwas | Chief Executive Officer | S — Open-market sale | 24.4K | $5.43 | $133K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for ABEONA THERAPEUTICS INC. (ABEO). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Vasanthavada Madhav | 5 | $174K |
| Vazzano Joseph Walter | 4 | $438K |
| O'Malley Brendan M. | 3 | $144K |
| Seshadri Vishwas | 3 | $775K |
| Alvino Mark | 2 | $35K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ABEO insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live ABEO dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.